Physician profile
George E Abraham
NPI 1518052257
$22,849.39
in general payments reported to CMS, 2019-2025
46 companies · $3,581 in 2025
The $3,581 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,367 · 2020: $757 · 2021: $3,160 · 2022: $5,787 · 2023: $5,166 · 2024: $2,033 · 2025: $3,581.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,605 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,150 · Travel and Lodging: $1,009 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,604.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,150.00 |
| Travel and Lodging | $1,008.96 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,989.83 | 2022-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $3,325.26 | 2019-2025 | Fasenra, Airsupra, Tagrisso |
| Glaxosmithkline, LLC. | $1,642.41 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,041.83 | 2019-2025 | Ofev, Jascayd |
| Actelion Pharmaceuticals US, INC. | $902.42 | 2019-2025 | Uptravi, Opsumit |
| Pfizer INC. | $761.41 | 2019-2025 | |
| Abbvie INC. | $592.79 | 2021-2025 | Avycaz, Teflaro |
| Mallinckrodt Hospital Products INC. | $453.63 | 2020-2025 | Acthar |
| Merck Sharp & Dohme LLC | $402.54 | 2019-2025 | Zerbaxa, Winrevair, Recarbrio |
| Regeneron Healthcare Solutions, INC. | $359.49 | 2021-2025 | Dupixent |
| United Therapeutics Corporation | $336.41 | 2019-2025 | Orenitram, Remodulin, Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $313.21 | 2019-2024 | |
| Pulmonx Corporation | $286.48 | 2020-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Genzyme Corporation | $281.08 | 2021-2025 | |
| Mallinckrodt Enterprises LLC | $239.93 | 2019 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $231.12 | 2019-2024 | Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $203.52 | 2023-2025 | Glassia |
| Ethicon INC. | $198.46 | 2019 | |
| Grifols USA, LLC | $197.87 | 2019-2025 | Prolastin-C Liquid |
| Sunovion Pharmaceuticals INC. | $183.26 | 2019 | |
| Veran Medical Technologies, INC. | $139.92 | 2019-2020 | |
| Astellas Pharma US INC | $138.67 | 2019-2022 | |
| Pinnacle Biologics, INC | $132.92 | 2021-2023 | Photofrin |
| Amgen INC. | $125.00 | 2022 | |
| Abiomed | $120.34 | 2023 | Impella |
| Olympus America INC. | $117.85 | 2021-2025 | Evis Exera II Ultrasonic Bronchofibervideoscope, Olympus |
| Vapotherm INC | $117.00 | 2020-2022 | |
| La Jolla Pharmaceutical Company | $105.82 | 2019-2025 | Giapreza |
| Inari Medical, INC. | $93.23 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Genentech USA, INC. | $91.94 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $82.94 | 2023-2024 | Xarelto |
| Allergan, INC. | $82.07 | 2019 | |
| Philips North America LLC | $81.87 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $70.70 | 2024-2025 | Purified Cortrophin Gel |
| Ambu INC. | $70.59 | 2025 | |
| Verona Pharma, INC. | $61.17 | 2025 | Ohtuvayre |
| Tetraphase Pharmaceuticals, INC. | $41.50 | 2019-2020 | |
| Mylan Specialty L.P. | $34.49 | 2019-2024 | Yupelri |
| Gilead Sciences, INC. | $34.12 | 2019 | |
| Circassia INC. | $33.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $29.23 | 2019-2020 | |
| Mauna Kea Technologies, INC. | $26.64 | 2024 | |
| Getinge USA Sales, LLC | $22.25 | 2024 | Base Unit Servo-U |
| Baxter Healthcare | $20.96 | 2024 | Hillrom - Life 2000 Ventilation System |
| Portola Pharmaceuticals, LLC | $17.52 | 2019 | |
| Becton, Dickinson and Company | $13.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.